Firefly Neuroscience (AIFF) News
NASDAQ: AIFFTechnologyComputer Software: Prepackaged SoftwareUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
AIFF news summary
We found 2 recent headlines mentioning Firefly Neuroscience (AIFF): 1 in the past week and 2 in the past 30 days, most often from GlobeNewswire. AIFF is making an outsized move today, down 9.64% at $0.75, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Firefly Neuroscience Reports 373% Year-Over-Year Increase in U18 ADHD Evoke™ Scans as Commercial Expansion Accelerates", was published by GlobeNewswire on Nov 17, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Firefly Neuroscience headlines
- Firefly Neuroscience Reports 373% Year-Over-Year Increase in U18 ADHD Evoke™ Scans as Commercial Expansion Accelerates4.7x expansion in scan volume bodes well for Firefly’s recent commercial partnership to cross-sell non-drug treatment for pediatric ADHD across its growing nationwide network of Evoke™ clinical…GlobeNewswire
- Firefly Neuroscience (NASDAQ: AIFF) Strengthens Non-Invasive Brain-Computer Interface Growth Strategy with Commercially Available Versus Platform– Firefly’s AI foundation model, being built on more than 200,000 standardized EEG/ERP brain scans, bolsters its long-term BCI growth opportunity –GlobeNewswire